This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

SunLink Health Systems, Inc. Announces Fiscal 2011 Third Quarter And Nine-Month Results

SunLink Health Systems, Inc. (NYSE Amex Equities: SSY) today announced earnings from continuing operations for its fiscal quarter ended March 31, 2011 of $2,515,000, or $0.31 per fully diluted share, compared to earnings from continuing operations of $469,000, or $0.06 per fully diluted share, for the comparable quarter ended March 31, 2010. For the nine months ended March 31, 2011, SunLink reported a loss from continuing operations of $1,849,000, or a loss of $0.23 per fully diluted share, compared to earnings from continuing operations of $691,000, or $0.09 per fully diluted share, for the nine months ended March 31, 2010. Net revenues for the quarter and nine months ended March 31, 2011 include $4,810,000 from Medicare and certain Medicaid Electronic Health Records Incentive Programs (“EHR Incentive Programs”). The results for the nine months ended March 31, 2010 included a pre-tax gain of $2,342,000 from the sale of three home health businesses.

SunLink reported net earnings of $2,683,000, or $0.33 per fully diluted share, for the quarter ended March 31, 2011, compared to net earnings of $1,646,000, or $0.20 per fully diluted share, for the comparable quarter a year ago. For the nine months ended March 31, 2011, SunLink reported a net loss of $1,851,000, or a loss of $0.23 per fully diluted share, compared to net earnings of $1,618,000, or $0.20 per fully diluted share for the comparable period last year.

Consolidated net revenues from continuing operations for the quarter ended March 31, 2011 increased by 7.4% to $52,028,000 compared to $48,462,000 in the comparable period a year ago. The Healthcare Facilities Segment net revenues of $39,337,000 in the current quarter increased $2,797,000, or 7.7%, from the prior year and included $4,810,000 from Medicare and certain Medicaid EHR Incentive Programs. Additional reimbursement under the EHR Incentive Programs is expected to be received through fiscal 2014 if the annual requirements of the programs are met. Also included in net revenues of the Healthcare Facilities Segment for the quarter ended March 31, 2011 is $1,948,000 from state indigent care programs and positive prior year third-party payor settlements compared to $2,614,000 in the quarter ended March 31, 2010. The Specialty Pharmacy Segment net revenues of $12,691,000 in the quarter ended March 31, 2011 increased $769,000, or 6.5% from the prior year. Consolidated net revenues from continuing operations for the nine months ended March 31, 2011 decreased by 1.1% to $137,947,000 compared to $139,551,000 in the comparable period a year ago. The Healthcare Facilities Segment had net revenues in the nine months ended March 31, 2011 of $104,871,000 compared to $105,369,000 last year. The Specialty Pharmacy Segment had $33,076,000 of net revenue for the nine months ended March 31, 2011 compared to $34,182,000 in the comparable period a year ago.

The company reported operating profit from continuing operations for the quarter ended March 31, 2011 of $5,687,000 compared to an operating profit for the quarter ended March 31, 2010 of $1,720,000. The operating profit in the current year increased $3,967,000, primarily due to increased earnings of the Healthcare Facilities Segment’s which included the reimbursement of $4,810,000 under EHR Incentive Programs.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs